News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pluristem Therapeuticss CEO Letter to Shareholders
May 23, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAIFA, Israel, May 23, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR) today announces the below CEO letter to shareholders:
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
·
2 min read
·
Heather McKenzie
China
Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector
September 17, 2025
·
8 min read
·
Tristan Manalac
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
·
2 min read
·
Tristan Manalac
